Publications by authors named "Vanessa ProSS"

Purpose: To study the potential of viscoelastic parameters such as liver stiffness, loss tangent (marker of viscous properties) and viscoelastic dispersion to detect hepatic inflammation by in-vivo and ex-vivo MR elastography (MRE) at low and high vibration frequencies.

Methods: 15 patients scheduled for liver tumor resection surgery were prospectively enrolled in this IRB-approved study and underwent multifrequency in-vivo MRE (30-60Hz) at 1.5-T prior to surgery.

View Article and Find Full Text PDF

Functional avidity is supposed to critically shape the quality of immune responses, thereby influencing host protection against infectious agents including SARS-CoV-2. Here we show that after human SARS-CoV-2 vaccination, a large portion of high-avidity spike-specific CD4+ T cells lost CD3 expression after in vitro activation. The CD3- subset was enriched for cytokine-positive cells, including elevated per-cell expression levels, and showed increased polyfunctionality.

View Article and Find Full Text PDF

Stem cell transplant recipients (SCTR) are imperiled to increased risks after SARS-CoV2 infection, supporting the need for effective vaccination strategies for this vulnerable group. With respect to pediatric patients, data on immunogenicity of SARS-CoV2 mRNA-based vaccination is limited. We therefore comprehensively examined specific humoral, B- and T cell responses in a cohort of 2-19 year old SCTR after the second and third vaccine dose.

View Article and Find Full Text PDF
Article Synopsis
  • Tissue-resident lymphocytes play a crucial role in defending organs against pathogens, but their response to vaccines in humans is less understood.
  • A study analyzed SARS-CoV-2 mRNA vaccine-specific T cells from various organs and blood of largely virus-naive individuals, revealing higher numbers of specific CD4+ T cells in nonlymphoid tissues compared to blood.
  • Findings suggest that vaccination leads to the development of memory T cells in organs far from the vaccination site, enhancing local immune protection in those tissues.
View Article and Find Full Text PDF

Protection of adult kidney transplant recipients against SARS-CoV2 was shown to be strongly impaired owing to low reactogenicity of available vaccines. So far, data on vaccination outcomes in adolescents are scarce due to later vaccination approval for this age group. We therefore comprehensively analyzed vaccination-specific humoral-, T- and B-cell responses in kidney transplanted adolescents aged 12-18 years in comparison to healthy controls 6 weeks after standard two-dose BNT162b2 ("Comirnaty"; Pfizer/BioNTech) vaccination.

View Article and Find Full Text PDF

Donor age is a major risk factor for allograft outcome in kidney transplantation. The underlying cellular mechanisms and the recipient's immune response within an aged allograft have yet not been analyzed. A comprehensive immunophenotyping of naïve and transplanted young versus aged kidneys revealed that naïve aged murine kidneys harbor significantly higher frequencies of effector/memory T cells, whereas regulatory T cells were reduced.

View Article and Find Full Text PDF

Transplant recipients exhibit an impaired protective immunity after SARS-CoV-2 vaccination, potentially caused by mycophenolate (MPA) immunosuppression. Recent data from patients with autoimmune disorders suggest that temporary MPA hold might greatly improve booster vaccination outcomes. We applied a fourth dose of SARS-CoV-2 vaccine to 29 kidney transplant recipients during a temporary (5 weeks) MPA/azathioprine hold, who had not mounted a humoral immune response to previous vaccinations.

View Article and Find Full Text PDF
Article Synopsis
  • Novel mRNA-based vaccines, like Comirnaty, have proven effective against COVID-19 but their impact on individuals with renal insufficiency and those on immunosuppressive medication is not fully understood.
  • A study analyzed kidney transplant recipients and found that a significantly low number showed immune responses (IgA and IgG seroconversion) after vaccination, compared to healthy individuals and hemodialysis patients.
  • Despite some T cell responses, kidney transplant patients had fewer and weaker immune responses, indicating a need for revised vaccination strategies and monitoring for this vulnerable population.
View Article and Find Full Text PDF